FemTech Market By Product Type (Wearable Devices {Basal Body Rings, Smartwatches, Smart Earrings, Thermoregulating Wristbands, Wearable Medical Bladder Control, Menstrual Cup Sensors}, Diagnostic and Monitoring Devices {Fetal Monitoring Devices, Breast Health Monitoring Devices, [Digital Breast Tomosynthesis, Automated Breast Ultrasound (ABUS)], Home Pregnancy Tests, Pregnancy Digital Biomarkers, Bone Density Testing, Others}), By Offering (Devices, Software, Services, Others), By Application (Pregnancy and Nursing Care, Reproductive Health & Contraception, Menstrual Health, General Health, Pelvic & Uterine Health, Sexual Health, Menopause Care, Others), By End User (Direct-to-consumer, Hospitals, Fertility clinics, Surgical centers, Diagnostic centers, Other), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The FemTech market accounted for USD 41.85 Billion in 2024 and is expected to reach USD 228.8 Billion by 2035, growing at a CAGR of around 16.7% between 2025 and 2035.  The FemTech market focuses on women’s health and wellness-related products or services. The emergence of FemTech-related technologies ranges from products focusing on reproductive health, pregnancy, and menopause to products tracking general health or wellness. FemTech solutions include mobile apps designed to track menstrual cycles and wearable technology to monitor hormonal changes. The FemTech market is continuously growing due to technological advancements and the increasing consumer demand for products designed to improve women's health.

Report Scope:

Market Dynamics

The increasing prevalence of chronic conditions like PCOS and endometriosis drives demand for management solutions.

The prevalence of chronic conditions such as Polycystic Ovary Syndrome (PCOS) and endometriosis is significantly driving the demand for FemTech solutions. As these conditions become more commonly known and diagnosed, the demand for innovative management of digital health solutions and technologies to serve women’s health increases. These technologies help to monitor the menstrual cycle and hormonal changes. About 10% of women in the world who are of reproductive age suffer from PCOS. 10 to 15% of fertile women have endometriosis, which also needs regular monitoring. A National Institute of Health Research states that 6.3 million women in the United States have endometriosis, while over 5 million women have PCOS. The prevalence of this disease drives the demand for management solutions that help women track their menstrual changes.

Complex regulatory requirements and long approval processes for medical devices and health apps.

The complex regulatory requirements imposed on medical devices and health apps in the form of extensive approval processes represent a significant barrier for the FemTech market. Most FemTech innovations, including fertility-tracking devices, menstrual health monitors, and apps for women's health, are characterized as medical devices requiring regulatory approval that involve compliance with strict guidelines. Additionally, with differing compliance standards across countries, multiple regional regulatory pathways will make it difficult for startups to identify appropriate global markets aside from their established market. The implications of time, cost, and regulatory complexities on product innovation and commercialization impact the scalability of FemTech products in general. Startups, many of whom have limited financial resources to expend on regulatory approvals, find themselves particularly challenged by regulatory standards, thereby limiting their ability.

Creation of wearables tailored to specific women's health needs, like hormonal monitoring and cycle tracking

Developing wearables focused on women's health needs (e.g., for hormonal monitoring and menstrual cycle tracking) presents a substantial opportunity in the market. These wearables will fill gaps in the healthcare landscape as they collect personalized, timely data about hormonal changes, fertility cycles, and menstrual cycles, which will empower women to manage their reproductive health. Sophisticated sensors and Artificial intelligence are used in these wearables to identify hormone changes in overall well-being, including stress, sleep, mood swings, hormonal shifts, and PCOS, particularly in women trying to conceive. 

Industry Experts Opinion

“To implement technologies that impact women’s health outcomes positively, we need accurate, quality data about conditions that pertain exclusively to women, such as contraception, fertility, maternal health, gynecology, menopause, and women’s oncology, and general health conditions where women’s differences are not comprehensively known or studied, such as Alzheimer’s, cardiovascular conditions, autoimmune diseases, migraines, and osteoporosis.”

• Susan Solinsky Director, HITLAB’s Women’s Health Tech initiative; Co-Founder and CGO, Ellipsis Health

“Two most significant gifts of technology for women are; democratization of health and discretion. FemTech allows dignity of privacy, should a woman choose not to involve another person in her health situation and let her receive customized help.” 

• Swathi Kulkarni, Co-founder and CEO of Elda Health

Segment Analysis

Based on the product type, FemTech Market has been classified into wearable devices, diagnostics and monitoring devices, and others. The most dominant segment in the FemTech market is wearable devices. These devices include smartwatches, basal body rings, and sensors in menstrual cups used for quick health monitoring and personalized wellness information. Wearables are convenient as they can be easily managed through digital health platforms to track health conditions like menstrual cycles, fertility, and pregnancy. Smartwatches and menstrual cup sensors are mostly used because of their multifunctionality and ease of use.

Based on the application type, the market of FemTech has been classified into Pregnancy and Nursing Care, Reproductive Health & Contraception, Menstrual Health, General Health, Pelvic & Uterine Health, Sexual Health, Menopause Care, and Others. The pregnancy and nursing care sector emerges as the most dominant segment in the Femech market. The increasing awareness among people regarding innovative solutions that can help prenatal and postnatal health leads to an increase in the demand for FemTech solutions. This segment’s prominence is due to rising maternal and child health concerns, the development of wearable technology, as well as personalized care provisions.

Regional Analysis

The North American FemTech market is showing substantial growth due to the growing awareness about women's health as well as the rapidly increasing demand for innovative delivery models. North America has a large ecosystem of startups and established companies in reproductive health, menstrual wellness, and menopause management. Many are harnessing technologies such as mobile apps and wearables to deliver personalized approaches to women's health. Supportive regulatory environments and increasing funding opportunities are sparking innovation. This market is a highly active market for FemTech development and growth.

The Asia Pacific FemTech market is experiencing rapid growth due to increasing consciousness about female health problems and digital health solutions. There is remarkable growth in reproductive health, fertility tracking solutions, and maternal care in some of the most significant markets, such as China, Japan, and India. An increase in healthcare infrastructure and government policies toward health care drives market growth. Mobile apps and telehealth services being embraced by many Asian countries’ populations are helping to increase access to these FemTech solutions.

Competitive Landscape 

The market for FemTech is highly competitive, with major players innovating around various aspects of women’s health, such as their menstrual cycles, reproductive health solutions, and wearable technology offered by Clue, Flo Health, and Elvie, among others. Menstrual products and pain solutions targeting menstruation have been brought into the market by Thinx and Livia. Flo Health received tremendous amounts of operating capital to improve its AI-powered health tracking abilities, while at the same time, Elvie launched an improved version of its smart breast pumps. In addition, Maven Clinic expanded its range of telehealth services, focusing on wider female health issues. Oura Health enhanced its passive health tracking features about women's health by adding more female ingredients to their rings.

FemTech Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In January 2024, Natural Cycles received approval from Health Canada to market its app as a form of birth control, marking the first time a fertility tracking app is authorized for contraceptive use in the country.
• In December 2023, HeraMED has teamed up with FemBridge, a leading maternal healthcare company, to expand its product portfolio and geographical reach. This collaboration aims to enhance HeraMED's presence in the maternal health sector and offer more comprehensive solutions to a wider audience.
• In June 2023, Flo Health Inc. introduced an open-source Anonymous Mode feature, enhancing privacy by allowing users to manage their health data securely while maintaining anonymity in the FemTech industry.

Report Coverage:

By Product Type

• Wearable Devices
  • Basal Body Rings
  • Smartwatches
  • Smart Earrings
  • Thermoregulating Wristbands
  • Wearable Medical Bladder Control
  • Menstrual Cup Sensors
• Diagnostic and Monitoring Devices
  • Fetal Monitoring Devices
  • Breast Health Monitoring Devices
    • Digital Breast Tomosynthesis
    • Automated Breast Ultrasound (ABUS)
  • Home Pregnancy Tests
  • Pregnancy Digital Biomarkers
  • Bone Density Testing
• Others

By Offering

• Devices
• Software
• Services
• Others

By Application

• Pregnancy and Nursing Care
• Reproductive Health & Contraception
• Menstrual Health
• General Health
• Pelvic & Uterine Health
• Sexual Health
• Menopause Care
• Others

End User

• Direct-to-consumer
• Hospitals
• Fertility clinics
• Surgical centers
• Diagnostic centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Clue
• Flo Health
• Elvie
• Ava
• Livia
• Thinx
• Moonmother
• Oura Health
• period
• Maven Clinic
• Tia
• Naya Health
• Keggle
• Hera Health
• MyFertilityMD

Frequently Asked Questions (FAQs)